According to a post on the FDA’s website, Mirati Therapeutics’ treatment of Mesothelioma was granted orphan designation. Reference Link
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on MRTX:
According to a post on the FDA’s website, Mirati Therapeutics’ treatment of Mesothelioma was granted orphan designation. Reference Link
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on MRTX: